{"disease":{"id":"erythema-chronicum-migrans","name":"erythema chronicum migrans"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03238274","title":"Sofia 2 Lyme FIA Whole Blood Clinical Study","phase":"","overall_status":"COMPLETED","enrollment_count":597,"lead_sponsor_name":"Quidel Corporation","has_results":false},{"nct_id":"NCT03584919","title":"Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans","phase":"NA","overall_status":"COMPLETED","enrollment_count":509,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT03153267","title":"Duration of Doxycycline Treatment in EM Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT03337932","title":"Duration of Doxycycline Treatment in MEM Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}